These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34650187)

  • 1. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.
    Salama AM; Momeni-Boroujeni A; Vanderbilt C; Ladanyi M; Soslow R
    Mod Pathol; 2022 Feb; 35(2):274-282. PubMed ID: 34650187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains.
    Ordi O; Saco A; Peñuelas N; Blanco-Irazuegui O; Pino MD; Carreras-Dieguez N; Marimon L; Rodrigo-Calvo MT; Morató A; Sisuashvili L; Bustamante M; Cruells A; Darecka K; Vega N; Alós S; Trias I; Fusté P; Parra G; Gut M; Munmany M; Torné A; Jares P; Rakislova N
    Mod Pathol; 2024 Oct; 37(10):100574. PubMed ID: 39089654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma.
    Choschzick M; Stergiou C; Gut A; Zoche M; Ross JS; Moch H
    Pathol Res Pract; 2023 Nov; 251():154877. PubMed ID: 37839360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.
    Watkins JC; Howitt BE; Horowitz NS; Ritterhouse LL; Dong F; MacConaill LE; Garcia E; Lindeman NI; Lee LJ; Berkowitz RS; Nucci MR; Crum CP
    Mod Pathol; 2017 Mar; 30(3):448-458. PubMed ID: 27834349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
    Corey L; Wallbillich JJ; Wu S; Farrell A; Hodges K; Xiu J; Nabhan C; Guastella A; Kheil M; Gogoi R; Winer I; Bandyopadhyay S; Huang M; Jones N; Wilhite A; Karnezis A; Thaker P; Herzog TJ; Oberley M; Korn WM; Vezina A; Morris R; Ali-Fehmi R
    Int J Gynecol Pathol; 2023 Sep; 42(5):515-522. PubMed ID: 37131274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
    Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A
    Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome.
    Gordinier ME; Schau GF; Pollock SB; Shields LBE; Talwalkar S
    Gynecol Oncol; 2024 Jan; 180():111-117. PubMed ID: 38086165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
    Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti MA; Rilke F
    Diagn Mol Pathol; 1995 Dec; 4(4):239-48. PubMed ID: 8634779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva.
    Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC
    Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Histologic and Molecular Spectrum of Highly Differentiated HPV-independent Cervical Intraepithelial Neoplasia.
    Regauer S; Reich O
    Am J Surg Pathol; 2023 Aug; 47(8):942-949. PubMed ID: 37283469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature.
    Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.